Aware Super’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.1M Sell
314,669
-13,334
-4% -$766K 0.26% 101
2026
Q1
$19.9M Buy
+328,003
New +$19.1M 0.3% 91
2025
Q3
$15.7M Hold
347,649
0.22% 115
2025
Q2
$16.1M Hold
347,649
0.24% 111
2025
Q1
$21.2M Hold
347,649
0.36% 89
2024
Q4
$19.7M Buy
+347,649
New +$19.4M 0.31% 100
2023
Q4
$18.8M Buy
+347,649
New +$18.2M 0.25% 101

Other funds holding BMY

Aware Super's BMY Position: Q2 2026 in Review

Aware Super reduced its Bristol-Myers Squibb (BMY) stake by 4.1% in Q2 2026, selling an estimated $766K and leaving 314,669 shares worth $18.1M. The position accounts for 0.26% of the portfolio, ranked #101.

Aware Super first reported a position in BMY in Q4 2023 and has held it in 7 quarters since. The position peaked at $21.2M in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Aware Super held 314,669 shares of Bristol-Myers Squibb worth $18.1M as of Q2 2026.
  • Aware Super sold 13,334 Bristol-Myers Squibb shares in Q2 2026, an estimated $766K.
  • Bristol-Myers Squibb made up 0.26% of Aware Super's portfolio in Q2 2026, its #101 holding.
  • Aware Super first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 7 quarters since.
  • Aware Super's Bristol-Myers Squibb position peaked at $21.2M in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Aware Super's 13F filing for Q2 2026, filed 29 Jul 2026.